Top of this page
Skip navigation, go straight to the content

Our Company Magazine Detail

Supporting neuroscience, sharing results

  • Posted by

    Modern medicine is powered by information. Doctors need data to make informed decisions about which therapy to prescribe for their patients; and patients are increasingly engaged in understanding their condition. UCB is also committed to deepening our own understanding of the clinical utility of our therapies.

    That is why we support research in the disease areas where we excel. At the Annual Meeting of the American Academy of Neurology (AAN) in Washington DC, April, 18-25, more than 20 presentations of data from UCB-sponsored studies were shared with delegates.

    The AAN's Annual Meeting, now in its 67th year, is among the premier neurology events in the world. It is an ideal venue for providing experts with the very latest information on our therapies for diseases such as epilepsy, Parkinson's disease and restless legs syndrome (RLS).

    The poster presentations addressed a wide variety of patient-centric issues ranging from studies of falls and fractures in older people with Parkinson's disease to research on seizure rates in patients who change epilepsy medication.

    Visitors to the UCB booth in the exhibit hall had the opportunity to meet some of the seizure response dogs from Canine Assistants. UCB is the proud sole sponsor of Canine Assistants seizure response dogs, a programme that provides specially trained service dogs to people with epilepsy.

    Since 2003, UCB’s support of this programme has covered the training and lifetime veterinary care for seizure response dogs for more than 260 people living with epilepsy.

    UCB's strong presence at the AAN meeting reflects our long-held commitment to improving the lives of patients by supporting and sharing new scientific knowledge.

  • Like

Leave a Comment


Posted by Humberto Fuentes, 27 May 2015 Strong focus in Parkinson's research will lead to amazing results